Health-related quality of life in chronic myeloid

Health-related quality of life in chronic myeloid leukemia
patients receiving long-term therapy with imatinib
compared with the general population
by Fabio Efficace, Michele Baccarani, Massimo Breccia, Giuliana Alimena,
Gianantonio Rosti, Francesco Cottone, Giorgio Lambertenghi Deliliers, Claudia
Baratè, Antonella Russo Rossi, Giuseppe Fioritoni, Luigia Luciano, Diamante Turri,
Bruno Martino, Francesco Di Raimondo, Melissa Dabusti, Micaela Bergamaschi,
Pietro Leoni, Maria Pina Simula, Luciano Levato, Stefano Ulisciani, Dino Veneri,
Simona Sica, Alessandro Rambaldi, Marco Vignetti, Franco Mandelli, and
Blood
Volume 118(17):4554-4560
October 27, 2011
©2011 by American Society of Hematology
Adjusted mean differences between CML patients and their respective control groups by age
categories.
Fabio Efficace et al. Blood 2011;118:4554-4560
©2011 by American Society of Hematology
Adjusted mean differences between CML patients and their respective control groups by sex.
Fabio Efficace et al. Blood 2011;118:4554-4560
©2011 by American Society of Hematology
Percentage of CML patients reporting the symptom by level of severity (N = 422).
Fabio Efficace et al. Blood 2011;118:4554-4560
©2011 by American Society of Hematology